<p>，/PRNewswire/ -- 律师广告 -- 全国知名律师事务所 Bronstein, Gewirtz &amp; Grossman, LLC 通知投资者，针对 LifeMD, Inc.（&#34;LifeMD&#34;或&#34;公司&#34;）（NASDAQ: LFMD）及其部分高管提起了集体诉讼。</p>
<p><strong>集体定义</strong></p>
<p>本诉讼旨在代表所有在 2025 年 5 月 7 日至 2025 年 8 月 5 日（包括这两个日期）期间购买或以其他方式获得 LifeMD 证券的个人和实体，向被告索赔，因其涉嫌违反联邦证券法。鼓励此类投资者通过访问该事务所网站加入此案：bgandg.com/LFMD。</p>
<p><strong>案件详情</strong></p>
<p>投诉书指控被告作出了虚假和/或误导性的陈述，和/或未能披露以下内容：（1）被告严重夸大了 LifeMD 的竞争地位；（2）被告在提高 LifeMD 的 2025 年指导时表现出鲁莽，因为他们没有正确考虑 LifeMD 的 RexMD 部门客户获取成本的上升，以及与销售旨在治疗肥胖的药物（包括 Wegovy 和 Zepbound）相关的客户获取成本；（3）因此，被告关于 LifeMD 的业务、运营和前景的陈述在所有相关时间都是严重虚假和误导的，且/或缺乏合理依据。</p>
<p><strong>接下来会发生什么？</strong></p>
<p>集体诉讼已经提起。如果您希望查看投诉书的副本，可以访问该事务所网站：bgandg.com/LFMD。或者您可以联系 Bronstein, Gewirtz &amp; Grossman, LLC 的 Peretz Bronstein 律师或其客户关系经理 Nathan Miller，电话 332-239-2660。如果您在 LifeMD 中遭受损失，您有直到 2025 年 10 月 27 日的时间请求法院任命您为首席原告。您分享任何赔偿的能力并不要求您担任首席原告。</p>
<p><strong>您无需支付费用</strong></p>
<p>我们以风险代理的方式代表投资者进行集体诉讼。这意味着我们将请求法院报销我们的自付费用和律师费，通常是总赔偿金额的一定比例，仅在我们成功的情况下。</p>
<p><strong>为什么选择 Bronstein, Gewirtz &amp; Grossman</strong></p>
<p>Bronstein, Gewirtz &amp; Grossman, LLC 是一家全国知名的律师事务所，代表投资者进行证券欺诈集体诉讼和股东派生诉讼。我们的事务所为全国投资者追回了数亿美元。</p>
<p>请在 LinkedIn、X、Facebook 或 Instagram 上关注我们以获取更新。</p>
<p>律师广告。以往结果不保证类似结果。</p>
<p><strong>联系方式</strong></p>
<p>Bronstein, Gewirtz &amp; Grossman, LLC</p>
<p>Peretz Bronstein 或 Nathan Miller</p>
<p>332-239-2660 | [email protected]</p>
<p>来源：Bronstein, Gewirtz &amp; Grossman, LLC</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTAxJk5ld3NJdGVtSWQ9REM2MTUyNyZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MDExMjAwUFJfTkVXU19VU1BSX19fX19EQzYxNTI3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTAxJk5ld3NJdGVtSWQ9REM2MTUyNyZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MDExMjAwUFJfTkVXU19VU1BSX19fX19EQzYxNTI3"/></p>

LFMD

<p>Bronstein, Gewirtz & Grossman, LLC 宣布对 LifeMD, Inc.（纳斯达克代码：LFMD）提起集体诉讼，指控其违反联邦证券法。该诉讼旨在为在 2025 年 5 月 7 日至 2025 年 8 月 5 日期间购买 LifeMD 证券的投资者追回损失。投诉称，LifeMD 的高管对公司的竞争地位和财务指引做出了误导性陈述。鼓励投资者在 2025 年 10 月 27 日截止日期之前联系该公司加入诉讼</p>

<p>, /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz &amp; Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against LifeMD, Inc. (&#34;LifeMD&#34; or &#34;the Company&#34;) (NASDAQ: LFMD) and certain of its officers.</p>
<div class="lb-trans"><p>，/PRNewswire/ -- 律师广告 -- 全国知名律师事务所 Bronstein, Gewirtz &amp; Grossman, LLC 通知投资者，针对 LifeMD, Inc.（&#34;LifeMD&#34;或&#34;公司&#34;）（NASDAQ: LFMD）及其部分高管提起了集体诉讼。</p>
</div><p><strong>Class Definition</strong></p>
<div class="lb-trans"><p><strong>集体定义</strong></p>
</div><p>This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired LifeMD securities between May 7, 2025 and August 5, 2025, both dates inclusive (the &#34;Class Period&#34;). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/LFMD.</p>
<div class="lb-trans"><p>本诉讼旨在代表所有在 2025 年 5 月 7 日至 2025 年 8 月 5 日（包括这两个日期）期间购买或以其他方式获得 LifeMD 证券的个人和实体，向被告索赔，因其涉嫌违反联邦证券法。鼓励此类投资者通过访问该事务所网站加入此案：bgandg.com/LFMD。</p>
</div><p><strong>Case Details</strong></p>
<div class="lb-trans"><p><strong>案件详情</strong></p>
</div><p>The complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that: (1) Defendants materially overstated LifeMD's competitive position; (2) Defendants were reckless in raising LifeMD's 2025 guidance, considering that they had not properly accounted for rising customer acquisition costs in LifeMD's RexMD segment, as well as for customer acquisition costs related to the sale of drugs designed to treat obesity, including Wegovy and Zepbound; and (3) as a result, Defendants' statements about LifeMD's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.</p>
<div class="lb-trans"><p>投诉书指控被告作出了虚假和/或误导性的陈述，和/或未能披露以下内容：（1）被告严重夸大了 LifeMD 的竞争地位；（2）被告在提高 LifeMD 的 2025 年指导时表现出鲁莽，因为他们没有正确考虑 LifeMD 的 RexMD 部门客户获取成本的上升，以及与销售旨在治疗肥胖的药物（包括 Wegovy 和 Zepbound）相关的客户获取成本；（3）因此，被告关于 LifeMD 的业务、运营和前景的陈述在所有相关时间都是严重虚假和误导的，且/或缺乏合理依据。</p>
</div><p><strong>What's Next?</strong></p>
<div class="lb-trans"><p><strong>接下来会发生什么？</strong></p>
</div><p>A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/LFMD. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz &amp; Grossman, LLC at 332-239-2660. If you suffered a loss in LifeMD you have until October 27, 2025, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.</p>
<div class="lb-trans"><p>集体诉讼已经提起。如果您希望查看投诉书的副本，可以访问该事务所网站：bgandg.com/LFMD。或者您可以联系 Bronstein, Gewirtz &amp; Grossman, LLC 的 Peretz Bronstein 律师或其客户关系经理 Nathan Miller，电话 332-239-2660。如果您在 LifeMD 中遭受损失，您有直到 2025 年 10 月 27 日的时间请求法院任命您为首席原告。您分享任何赔偿的能力并不要求您担任首席原告。</p>
</div><p><strong>There is No Cost to You</strong></p>
<div class="lb-trans"><p><strong>您无需支付费用</strong></p>
</div><p>We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.</p>
<div class="lb-trans"><p>我们以风险代理的方式代表投资者进行集体诉讼。这意味着我们将请求法院报销我们的自付费用和律师费，通常是总赔偿金额的一定比例，仅在我们成功的情况下。</p>
</div><p><strong>Why Bronstein, Gewirtz &amp; Grossman</strong></p>
<div class="lb-trans"><p><strong>为什么选择 Bronstein, Gewirtz &amp; Grossman</strong></p>
</div><p>Bronstein, Gewirtz &amp; Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.</p>
<div class="lb-trans"><p>Bronstein, Gewirtz &amp; Grossman, LLC 是一家全国知名的律师事务所，代表投资者进行证券欺诈集体诉讼和股东派生诉讼。我们的事务所为全国投资者追回了数亿美元。</p>
</div><p>Follow us for updates on LinkedIn, X, Facebook, or Instagram.</p>
<div class="lb-trans"><p>请在 LinkedIn、X、Facebook 或 Instagram 上关注我们以获取更新。</p>
</div><p>Attorney advertising. Prior results do not guarantee similar outcomes.</p>
<div class="lb-trans"><p>律师广告。以往结果不保证类似结果。</p>
</div><p><strong>Contact</strong></p>
<div class="lb-trans"><p><strong>联系方式</strong></p>
</div><p>Bronstein, Gewirtz &amp; Grossman, LLC</p>
<div class="lb-trans"><p>Bronstein, Gewirtz &amp; Grossman, LLC</p>
</div><p>Peretz Bronstein or Nathan Miller</p>
<div class="lb-trans"><p>Peretz Bronstein 或 Nathan Miller</p>
</div><p>332-239-2660 | [email protected]</p>
<div class="lb-trans"><p>332-239-2660 | [email protected]</p>
</div><p>SOURCE Bronstein, Gewirtz &amp; Grossman, LLC</p>
<div class="lb-trans"><p>来源：Bronstein, Gewirtz &amp; Grossman, LLC</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTAxJk5ld3NJdGVtSWQ9REM2MTUyNyZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MDExMjAwUFJfTkVXU19VU1BSX19fX19EQzYxNTI3" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DC61527&amp;Transmission_Id=202509011200PR_NEWS_USPR_____DC61527&amp;DateId=20250901"/></p>

12:00 ET
			
			
				LFMD INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that LifeMD, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

LifeMD 投资者警报：Bronstein, Gewirtz & Grossman LLC 宣布，LifeMD, Inc.的投资者如果遭受重大损失，有机会主导集体诉讼